Faisal Khursheed Siddiqi, MD, a cardiac electrophysiologist at Hamilton Cardiology Associates in Hamilton Township, New Jersey, has left to join the staff at Lourdes Cardiology in another city in the state, Haddon Heights, according to a recent report from the Burlington County Times.

Germany-based Biotronik has launched its smallest and lightest set of heart pacemakers, branded the Edora series, which specialize in patient safety, therapy and comfort while being MR-conditional.

With the launch of the Merit-based Incentive Payment System (MIPS), hundreds of thousands of U.S. clinicians will face new reporting requirements. Participation in a registry, a familiar quality improvement activity for many cardiology programs, could provide a solution.     

The American Heart Association and American Stroke Association say that palliative care should be integrated into the care of all patients with advanced cardiovascular disease and stroke as a means to relieve symptoms, improve patients’ satisfaction with their care, reduce costs and extend survival (Circulation 2016;134[11]: e198-225). Yet, according to 2015 data from the National Palliative Care Registry, only 13 percent of palliative care patients had a cardiac diagnosis. This finding signals the need for both increased referrals to palliative care and more training for cardiovascular specialists in core palliative care skills.

Electronic health records (EHRs) have transformed the way clinical care is recorded and reimbursed, and now their promise for reaching across large populations is making them a key resource for cardiovascular research.  

On the final day of this year’s American College of Cardiology (ACC) conference, Mary Norine Walsh, MD, assumed her role as the president of the organization.

Moderate alcohol consumption was associated with a lower risk of several cardiovascular diseases compared with not drinking and heavy drinking, according to a population-based cohort study in the United Kingdom.

Findings presented at the American College of Cardiology’s 66th Annual Scientific Session show that adding a cholesterol-lowering drug to treatment with a statin has no effect on cognition and thinking.